Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies

✍ Scribed by R.A. Sharma; W.P. Steward; C.A. Daines; R.D. Knight; K.J. O’Byrne; A.G. Dalgleish

• Book ID: 116429058
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 153 KB
• Volume: 42
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2006.05.018